Program Overview
This CME program is derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2024 Course. The expert faculty, Dr. Aaron Miller, will start by analyzing the unmet needs for patients with relapsing multiple sclerosis (RMS) including tolerance and adherence to long-term treatment. Following, he will review the clinical trial data for new and emerging injectable therapies, including glatiramer acetate (GA) depot for the treatment of multiple sclerosis. To conclude, Dr. Miller will discuss individualized strategies for patient education, shared decision making, and overcoming barriers to treatment adherence for patients with multiple sclerosis.
Target Audience
MS specialists, other neurologists, and other healthcare professionals involved in the management of patients with multiple sclerosis
Learning Objective
- Review the unmet needs for patients with relapsing multiple sclerosis including tolerance and adherence to long-term treatment.
- Analyze the clinical trial data for new and emerging injectable therapies including glatiramer acetate depot for the treatment of multiple sclerosis.
- Apply updated individualized strategies for patient education, shared decision making, and overcoming barriers to treatment adherence.
Faculty
Aaron Miller, MD
Medical Director
Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Professor of Neurology
Icahn School of Medicine at Mount Sinai
New York, NY
Disclosures of Relevant Financial Relationships
It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships relating to the topics of this educational activity. Any relevant financial relationships are mitigated via a content review by planning committee members and faculty with no relevant financial relationships.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
| Faculty | Relationship Identified With: |
| Aaron Miller, MD | Consultant/Advisor: Accordant; Amgen, Inc.; CorEvitas, LLC; Mapi-Pharma Ltd; Mylan Specialty L.P., a Viatris Company
Speaker: Alexion Pharmaceuticals, Inc.; Amgen, Inc.; Biogen |
Planners and Peer Reviewers
Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC; Chelsey Simonds and Nicole McMenamin hereby state that they or their spouse/life partner do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.
Accreditation Statement
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AcademicCME designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM.
Learners should only claim credit commensurate with the extent of their participation.
Financial Support
This activity has been supported by an independent educational grant from Mylan Specialty L.P., a Viatris Company.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Mylan Specialty L.P., a Viatris Company do not recommend the use of any agent outside of the labeled indications.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
In order to claim credit, participants must complete the following:
- Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
- Complete the Pre-Activity Questions
- Read or Review the activity content.
- Complete the Post-Activity Test Questions and Evaluation.
- Learners who receive a grade of 60% or better on the Post-Activity Test Questions and complete the Evaluation will receive appropriate credit as indicated (CME, CNE, and/or CPE credit).
- CME and CNE credit will be issued appropriate certificate of completion.
- Others may request a “certificate of completion”.
- Learners should claim only the credit commensurate with the extent of their participation in the activity.
CE Inquiries/Special Needs
For all CE inquiries or special needs, please contact [email protected].
